Compare MTX & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MTX | HTFL |
|---|---|---|
| Founded | 1968 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Major Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2004 | N/A |
| Metric | MTX | HTFL |
|---|---|---|
| Price | $75.61 | $29.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $82.00 | $38.20 |
| AVG Volume (30 Days) | 211.3K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $2,072,600,000.00 | N/A |
| Revenue This Year | $5.66 | $27.66 |
| Revenue Next Year | $4.47 | $23.55 |
| P/E Ratio | $64.37 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $53.15 | $20.13 |
| 52 Week High | $84.34 | $41.22 |
| Indicator | MTX | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 53.15 |
| Support Level | $65.38 | $28.60 |
| Resistance Level | $84.34 | $32.71 |
| Average True Range (ATR) | 2.59 | 1.92 |
| MACD | -0.62 | -0.23 |
| Stochastic Oscillator | 21.44 | 66.01 |
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.